The FINANCIAL - Finchannel.com - CORONAVIRUS UPDATE

FDA authorizes drug combination for coronavirus treatment

The FINANCIAL -- The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation ...

NIH: Hydroxychloroquine does not benefit adults hospitalized with coronavirus

The FINANCIAL -- A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has ...

Pfizer and BioNTech coronavirus vaccine candidate found to be more than 90% effective

The FINANCIAL -- Pfizer Inc. and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in ...

EU launches €280 mln financing initiative to support Covid-19 impacted business

The FINANCIAL -- As part of Team Europe’s response to the Covid-19 pandemic, eleven members of EDFI, the Association of European Development Finance Institutions, are strengthening cooperation with ...

FDA authorizes monoclonal antibody for treatment of COVID-19

The FINANCIAL -- The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of ...

AA, BA and oneworld airline alliance launch transatlantic COVID-19 testing

The FINANCIAL -- American Airlines, British Airways and oneworld® have launched an optional coronavirus (COVID-19) medical-based testing trial on select flights from cities in the United States to ...

Moderna coronavirus vaccine shows 94.5 % efficacy in Phase 3 trial

The FINANCIAL -- Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that ...

Johnson & Johnson Initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate

The FINANCIAL -- The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen ...

Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate

The FINANCIAL -- Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are pleased to announce the start of Phase 2/3 clinical trials of its plant-derived vaccine candidate for ...

2 in 3 Americans and 3 in 4 Britons are happy to receive coronavirus vaccine

The FINANCIAL -- After a vaccine presenting as 90% effective in stage three clinical trials was announced by Pfizer on Monday, 76% of Britons and 66% of Americans say they would be happy to be ...

People who identify as “conscientious” are 31% more likely to follow covid-19 guidelines

The FINANCIAL -- People who describe themselves as having “conscientious” personality traits are 31% more likely to follow covid-19 guidelines, according to new research from emlyon business ...

Other

User pages

Main Menu

FDA authorizes drug combination for coronavirus treatment

NIH: Hydroxychloroquine does not benefit adults hospitalized with coronavirus

Pfizer and BioNTech coronavirus vaccine candidate found to be more than 90% effective

EU launches €280 mln financing initiative to support Covid-19 impacted business

FDA authorizes monoclonal antibody for treatment of COVID-19

AA, BA and oneworld airline alliance launch transatlantic COVID-19 testing

Moderna coronavirus vaccine shows 94.5 % efficacy in Phase 3 trial

Johnson & Johnson Initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate

Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate

2 in 3 Americans and 3 in 4 Britons are happy to receive coronavirus vaccine

People who identify as “conscientious” are 31% more likely to follow covid-19 guidelines

Popular in COVID-19

Get in Touch

Resource

Guidebook

Follow us

Terms